This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Dublin, March 15, 2018 (GLOBE NEWSWIRE) -- The "Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market ...
An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, the phase II randomized HUMBOLDT trial showed.
Please provide your email address to receive an email when new articles are posted on . Data derived from Chauhan MZ, et al. Ophthalmol Glaucoma. 2025;doi:10.1016/j ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A 29-year-old woman was referred to Tufts Medical Center ...
Early-onset, chronic nonanterior uveitis in children increases the risk of ocular complications, with 44.3% experiencing issues like cataracts and macular edema. Persistent chronic uveitis is a ...
The report on Uveitis clinical trials highlights opportunities in understanding trial count, enrollment trends, and successful trial regions. It aids strategic investment decisions by identifying key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results